Publications from the Centre for Immuno-Oncology
A radioiodinated rucaparib analogue as an Auger electron emitter for cancer therapy.
Destro G. et al, (2023), Nuclear medicine and biology, 116-117
Correlation between molar activity, injection mass and uptake of the PARP targeting radiotracer [18F]olaparib in mouse models of glioma.
Chan CY. et al, (2022), EJNMMI research, 12
Imaging PARP with [18F]rucaparib in pancreatic cancer models.
Chan CY. et al, (2022), European journal of nuclear medicine and molecular imaging, 49, 3668 - 3678
Non-invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma.
Tan KV. et al, (2022), Journal of visualized experiments : JoVE
Radiofluorination of a highly potent ATM inhibitor as a potential PET imaging agent.
Fraser CR. et al, (2022), EJNMMI research, 12
Radiofluorination of A Highly Potent ATM Inhibitor As A Potential PET Imaging Agent
Claudia Fraser1 None. et al, (2022)
Copper-Mediated Radiosynthesis of [18F]Rucaparib.
Chen Z. et al, (2021), Organic letters, 23, 7290 - 7294
Copper-based reactions in analyte-responsive fluorescent probes for biological applications.
Au-Yeung HY. et al, (2017), Journal of inorganic biochemistry, 177, 300 - 312
Rhenium(i) complexes of N-heterocyclic carbene ligands that bind to amyloid plaques of Alzheimer's disease.
Chan CY. et al, (2017), Chemical communications (Cambridge, England), 53, 2311 - 2314
Rhenium complexes of bidentate, bis-bidentate and tridentate N-heterocyclic carbene ligands.
Chan CY. and Barnard PJ., (2015), Dalton transactions (Cambridge, England : 2003), 44, 19126 - 19140
Rhenium and technetium tricarbonyl complexes of N-heterocyclic carbene ligands.
Chan CY. et al, (2014), Inorganic chemistry, 53, 10862 - 10873